Potent Neutralizing Activity of Polyclonal Equine Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of ConcernArticle Published on 2022-12-282023-07-10 Journal: The Journal of Infectious Diseases [Category] COVID19(2023년), [키워드] COVID-19 Neutralizing antibodies omicron SARS-CoV-2 variants of concern. [DOI] 10.1093/infdis/jiac331 PMC 바로가기
One-Year Follow-Up of COVID-19 Patients Indicates Substantial Assay-Dependent Differences in the Kinetics of SARS-CoV-2 AntibodiesArticle Published on 2022-12-212023-07-10 Journal: Microbiology Spectrum [Category] COVID19(2023년), [키워드] antibody kinetics assay comparison Neutralizing antibodies predictive modelling. SARS-CoV-2 [DOI] 10.1128/spectrum.00597-22 PMC 바로가기
Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in ColombiaArticle Published on 2022-12-212023-07-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), [키워드] COVID-19 Neutralizing antibodies omicron SARS-CoV-2 vaccine. [DOI] 10.3389/fimmu.2022.1102384 PMC 바로가기
Anti-Arbovirus Antibodies Cross-React With Severe Acute Respiratory Syndrome Coronavirus 2Article Published on 2022-12-212023-07-10 Journal: Microbiology Spectrum [Category] COVID19(2023년), [키워드] arbovirus Chikungunya virus cross-protection dengue virus Neutralizing antibodies SARS-CoV-2 serological cross-reactivity. [DOI] 10.1128/spectrum.02639-22 PMC 바로가기
In Vitro Diagnostic Assay to Detect SARS-CoV-2-Neutralizing Antibody in Patient Sera Using Engineered ACE-2 Mini-ProteinArticle Published on 2022-12-182023-07-11 Journal: Viruses [Category] COVID19(2023년), [키워드] ACE2 engineered mini-protein in vitro diagnostics Neutralizing antibodies SARS-CoV-2 spike protein. [DOI] 10.3390/v14122823 PMC 바로가기
Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopesArticle Published on 2022-12-132023-07-10 Journal: Immunity [Category] COVID19(2023년), [키워드] coronavirus COVID-19 Cryo-electron microscopy mosaic nanoparticle Neutralizing antibodies sarbecovirus SARS-CoV-2 Vaccine design. X-ray crystallography [DOI] 10.1016/j.immuni.2022.10.019 PMC 바로가기
Single-dose rAAV5-based vaccine provides long-term protective immunity against SARS-CoV-2 and its variantsArticle Published on 2022-12-092023-07-11 Journal: Virology Journal [Category] COVID19(2023년), [키워드] Neutralizing antibodies rAAV5. SARS-CoV-2 Vaccine Virus challenge [DOI] 10.1186/s12985-022-01940-w PMC 바로가기
High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cellsArticle Published on 2022-12-052023-07-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), [키워드] CD4 function CD4 T cells Neutralizing antibodies proliferation. SARS-CoV-2 [DOI] 10.3389/fimmu.2022.1032911 PMC 바로가기
Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial재조합 인터페론 무장 융합 단백질 백신(V-01)을 사용한 SARS-CoV-2에 대한 이종 부스팅의 효능: 무작위, 이중 맹검 및 위약 대조 3상 시험Clinical Trial Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 임상, 진단, [키워드] adverse event antibody assigned booster clinical trial common adverse event conducted COVID-19 vaccine COVID-19 vaccines dose double-blind dramatic increase Efficacy elicit eligible fatigue Fever fusion protein groups headache healthy Heterologous heterologous boosting Humoral immunity Identifier Immunity inactivated Inactivated vaccine Inactivated Vaccines Inc injection injection site intention-to-treat principle Malaysia Mild-to-moderate Neutralizing Neutralizing antibodies occurred Older omicron Omicron variant over Pain participant Participants Placebo placebo-controlled primary endpoint Randomized Randomly receive regimen robust Safe SARS-CoV-2 SARS-COV-2 infection second dose Serious Adverse Events subunit Subunit vaccine Subunit vaccine. Surveillance symptomatic SARS-CoV-2 infection the epidemic titre Trial Trial registration V-01 Vaccine vaccine efficacy variant virus-neutralizing antibodies was measured were assessed [DOI] 10.1080/22221751.2022.2088406 PMC 바로가기 [Article Type] Clinical Trial
SARS-CoV-2 vaccines: A double-edged sword throughout rapid evolution of COVID-19Review Published on 2022-12-012023-07-10 Journal: Cell biology international [Category] COVID19(2023년), [키워드] Antibody-dependent enhancement Neutralizing antibodies SARS-CoV-2 vaccine. [DOI] 10.1002/cbin.11903 PMC 바로가기 [Article Type] Review